Loading...

Cerevel Therapeutics Holdings, Inc.

CERE•NASDAQ
Healthcare
Biotechnology
$44.96
$0.33(0.74%)

Cerevel Therapeutics Holdings, Inc. (CERE) Stock Chart & Performance Analysis

Explore Cerevel Therapeutics Holdings, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.74%
3-Month Change
10.63%
6-Month Change
9.66%
Year-to-Date (YTD) Change
6.52%
1-Year Change
87.88%
3-Year Change
45.17%
5-Year Change
277.82%
All-Time (Max) Change
277.82%

Analyzing Cerevel Therapeutics Holdings, Inc. (CERE) Trends Across Multiple Time Frames

Cerevel Therapeutics Holdings, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Cerevel Therapeutics Holdings, Inc. stock shows N/A 1-day change, indicating low volatility, while its 5-day change of N/A suggests a broader trend. Over a 1-month period, a 0.74% rise could signal a pushback, whereas a 3-month rise of 10.63% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 9.66% and a YTD rise of 6.52% might concern investors, but a 1-year gain of 87.88% and a 3-year increase of 45.17% could indicate resilience. The 5-year surge of 277.82% highlights strong historical growth, while the all-time return of 277.82% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;